 Todos Medical Ltd announced that its subsidiary 3CL Pharma Ltd has received a new certificate of free sale CFS for its Tollovid dietary supplement. The CFS from the US Food Drug Administration provides for both a five-day support dosing regimen and a 30-day maintenance dosing regimen of Tollovid Maximum Strength, and reiterates the 3CL protease in vitro inhibitor language allowed on prior labels for Tollovid, according to a statement. 